| Application of the Bayesian spline method to analyze real-time measurements of ultrafine particle concentration in the Parisian subway R Pétremand, P Wild, C Crézé, G Suarez, S Besançon, V Jouannique, ... Environment International 156, 106773, 2021 | 11 | 2021 |
| TCR sequencing and cloning methods for repertoire analysis and isolation of tumor-reactive TCRs R Genolet, S Bobisse, J Chiffelle, M Arnaud, R Petremand, L Queiroz, ... Cell Reports Methods 3 (4), 2023 | 10 | 2023 |
| Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8+ T-myeloid cell networks in melanoma D Barras, E Ghisoni, J Chiffelle, A Orcurto, J Dagher, N Fahr, F Benedetti, ... Science Immunology 9 (92), eadg7995, 2024 | 7 | 2024 |
| A real-time comparison of four particulate matter size fractions in the personal breathing zone of Paris subway workers: A six-week prospective study R Pétremand, G Suárez, S Besançon, JH Dil, I Guseva Canu Sustainability 14 (10), 5999, 2022 | 7 | 2022 |
| A phase 1 trial of adoptive transfer of vaccine-primed autologous circulating T cells in ovarian cancer S Bobisse, V Bianchi, JL Tanyi, A Sarivalasis, E Missiaglia, R Pétremand, ... Nature Cancer 4 (10), 1410-1417, 2023 | 6 | 2023 |
| Tumor-reactive clonotype dynamics underlying clinical response to TIL therapy in melanoma J Chiffelle, D Barras, R Petremand, A Orcurto, S Bobisse, M Arnaud, ... bioRxiv, 2023.07. 21.544585, 2023 | 3 | 2023 |
| Cancer vaccines based on whole-tumor lysate or neoepitopes with validated HLA binding outperform those with predicted HLA-binding affinity H Fritah, M Graciotti, CLL Chiang, AL Huguenin-Bergenat, R Petremand, ... Iscience 26 (4), 2023 | 1 | 2023 |
| Tumor microenvironment cellular crosstalk predicts response to adoptive TIL therapy in melanoma D Barras, E Ghisoni, J Chiffelle, A Orcurto, J Dagher, N Fahr, F Benedetti, ... bioRxiv, 2022.12. 23.519261, 2022 | 1 | 2022 |
| Identification of clinically relevant T cell receptors for personalized T cell therapy using combinatorial algorithms R Pétremand, J Chiffelle, S Bobisse, MAS Perez, J Schmidt, M Arnaud, ... Nature Biotechnology, 1-6, 2024 | | 2024 |
| 182P Cancer vaccines based on whole-tumor-lysate or neoepitopes with validated HLA-binding outperform those with predicted HLA-binding affinity L Kandalaft, H Fritah, M Graciotti, C Chiang, R Petremand, P Guillaume, ... Immuno-Oncology and Technology 16, 2022 | | 2022 |
| Prognosis and Therapeutic Response Transfer Learning Model for Multiple Myeloma J Voegeli, D Moreno, M Kryukov, G Mathez, R Petremand, A Pere, ... Blood 138, 1883, 2021 | | 2021 |
| Régime alimentaire des Sérotines communes du Val-de-Travers: menaces potentielles des parcs éoliens sur la survie de l'espèce R Pétremand | | 2013 |
